1. Home
  2. SNFCA vs TNXP Comparison

SNFCA vs TNXP Comparison

Compare SNFCA & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

HOLD

Current Price

$9.20

Market Cap

234.1M

Sector

Finance

ML Signal

HOLD

Logo Tonix Pharmaceuticals Holding Corp.

TNXP

Tonix Pharmaceuticals Holding Corp.

HOLD

Current Price

$15.07

Market Cap

220.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SNFCA
TNXP
Founded
1965
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
234.1M
220.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SNFCA
TNXP
Price
$9.20
$15.07
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$70.00
AVG Volume (30 Days)
33.4K
371.9K
Earning Date
03-30-2026
03-17-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.74
N/A
Revenue
$340,876,482.00
$10,299,000.00
Revenue This Year
N/A
$7.00
Revenue Next Year
N/A
$708.37
P/E Ratio
$11.77
N/A
Revenue Growth
3.25
N/A
52 Week Low
$7.32
$6.76
52 Week High
$12.71
$69.97

Technical Indicators

Market Signals
Indicator
SNFCA
TNXP
Relative Strength Index (RSI) 56.83 39.26
Support Level $8.80 $14.98
Resistance Level $9.50 $16.69
Average True Range (ATR) 0.28 1.07
MACD 0.05 -0.23
Stochastic Oscillator 69.70 5.50

Price Performance

Historical Comparison
SNFCA
TNXP

About SNFCA Security National Financial Corporation

Security National Financial Corp is engaged in the life insurance, cemetery and mortuary, and mortgage loan businesses. The life insurance segment is engaged in the business of selling and servicing selected lines of life insurance, annuity products, and accident and health insurance. Its cemetery and mortuary segment consists of approximately seven mortuaries and five cemeteries in the state of Utah and a cemetery in the state of California. The mortgage loan segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and real estate projects. Geographically, all the business activity is functioned through the region of the USA and it derives the majority of revenue from Mortgage segment.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: